Physician profile
Priya Vasdev
NPI 1942221197
$886.49
in general payments reported to CMS, 2019-2025
16 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $94.71 · 2021: $71.33 · 2022: $108 · 2023: $85.63 · 2024: $62.82 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $166.92 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $145.72 | 2025 | Rexulti |
| Novo Nordisk INC | $122.51 | 2019-2023 | Rybelsus, Ozempic |
| Amgen INC. | $96.69 | 2022-2025 | Evenity, Prolia |
| Pfizer INC. | $52.67 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $47.17 | 2019-2023 | Nuplazid |
| Janssen Pharmaceuticals, INC | $38.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $37.29 | 2020 | |
| Biogen, INC. | $31.01 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $26.98 | 2024 | |
| Avanir Pharmaceuticals, INC. | $24.09 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.45 | 2025 | Xifaxan |
| Exact Sciences Corporation | $21.20 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $18.29 | 2021 | |
| Gilead Sciences, INC. | $17.73 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Vasdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.